副作用集計データに基づく副作用評価と患者説明書作成への取り組み : R-CHOP療法

概要

論文の詳細を見る
We collected data on adverse reactions due to R-CHOP chemotherapy in our hospital from November 2005 to November 2006 from electronic clinical records and then conducted a retrospective analysis of adverse effect data for malignant lymphoma patients. The results of our survey for the first time R-CHOP therapy was administered indicated high incidences for infusion reactions (52.6%), constipation (71.6%), neutropenia (96.6%) and leukocytopenia (83.3%). Based on the results, we prepared a brochure entitled "Explanation of adverse effects of R-CHOP therapy". The objectives of preparing the brochure were to minimize inter-individual differences between the pharmaceutical care and drug consultation provided by clinical pharmacists and ensure that patients had a good understanding of their treatment. We are sure that this kind of activity will help us to provide better pharmaceutical care for patients.
2009-02-10